CHRYSTAL SOUDER: Open Payments
NPI 1164958609 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 25 payments from 11 companies in 2025. Trend: 2023 $753 · 2024 $621 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $162 |
| Lilly USA, LLC | 4 | $60 |
| PFIZER INC. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, NURTEC ODT, XIFAXAN, Cologuard Collection Kit, MOUNJARO, JARDIANCE, UBRELVY, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
